Integrins in the Endothelial Response to Fluid Shear Stress
Integrins in the Endothelial Response to Fluid Shear Stress
批准号:
8413258
负责人:
Martin A Schwartz
金额:
$41.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-12-29 至 2014-04-30
关键词:
AffinityApolipoprotein EArterial Fatty StreakArteriesAtherosclerosisBehaviorBindingBiochemicalBlood VesselsBlood flowCD31 AntigensCaliberCellsCessation of lifeChimera organismChronicComplementComplexCytoplasmic TailDataDevelopmentDiabetes MellitusDiseaseDrug Delivery SystemsEmbryonic DevelopmentEndothelial CellsEndotheliumEventExtracellular MatrixGene ExpressionGenesGoalsHealthHyperlipidemiaInflammatoryIntegrin BindingIntegrinsIntercellular JunctionsLaboratoriesLeadLinkLiquid substanceMeasuresMechanicsMediatingMediator of activation proteinModelingMolecularMolecular ModelsMusMyocardial InfarctionN-CadherinPathway interactionsPatternPeptidesPhysiologicalPhysiologyPlayProtein KinaseProtein Tyrosine KinaseProteinsRisk FactorsRoleSignal TransductionSiteSpecificityStretchingStrokeSystemTestingTransducersUnited StatesVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-2Vascular SystemWorkatherogenesiscadherin 5constrictioncytokineeffective therapyfluid flowin vivoinhibitor/antagonistmolecular modelingnovelp21 activated kinasepreventresponsesensorshear stressvascular inflammation
中文摘要
描述(由申请人提供):内皮细胞的基因表达和行为受到来自流动血液的流体剪切应力的高度调节。内皮细胞对血流的反应调节血管胚胎发生、正常血管生理和动脉粥样硬化的发展。我们之前的工作发现了一个由PECAM-1、VE-cadherin和VEGF受体2组成的机械转导复合体,它位于细胞-细胞连接处,并在该系统中介导力向生化信号的转化。PECAM-1似乎是真正的力传感器,VE-cadherin作为适配器将VEGFR2带入复合体,VEGFR酪氨酸激酶启动关键的下游信号。这些信号包括整合素向高亲和力状态的转化,这导致它们与细胞外基质结合。这些新结合的整合素然后产生信号。与该模型一致,内皮细胞下的细胞外基质对血流诱导的信号进行了关键调节。特别是,PAK (p21活化激酶)介导了这种基质特异性的关键方面。目前的项目旨在阐明连接机械转导复合物的分子转导机制,并在体内测试PAK在动脉粥样硬化中的作用。为了实现这些总体目标,我们将:1)测量PECAM-1的力并阐明PECAM-1细胞质结构域在机械转导中的作用。2)通过VE-cadherin鉴定介导适配器功能的蛋白相互作用。3)检查pak缺陷小鼠的血管炎症和动脉粥样硬化。公共卫生相关性:动脉粥样硬化是动脉的慢性炎症性疾病。在美国,大约一半的死亡是由心脏病发作、中风或其他与动脉粥样硬化相关的血管事件引起的。虽然高脂血症和糖尿病等危险因素是重要的危险因素,但动脉粥样硬化是在易受流体流动干扰的动脉区域开始并维持的。本项目将研究动脉机械转导导致动脉粥样硬化的分子机制。了解流体剪切应力如何诱导血管炎症可能会确定新的药物靶点,从而导致更有效的治疗方法来预防或治疗这些疾病。
英文摘要
DESCRIPTION (provided by applicant): Endothelial cell gene expression and behavior is highly regulated by fluid shear stress from flowing blood. Endothelial responses to flow regulate vascular embryogenesis, normal vascular physiology and development of atherosclerosis. Our previous work identified a mechanotransduction complex consisting of PECAM-1, VE-cadherin and VEGF receptor 2 that resides at cell-cell junctions and mediates conversion of force to biochemical signals in this system. PECAM-1 appears to be the true force transducer, VE-cadherin functions as an adapter that brings VEGFR2 into the complex and the VEGFR tyrosine kinase initiates key downstream signals. These signals include conversion of integrins to high affinity states, which leads to their binding to extracellular matrix. These newly bound integrins then generate signals. Consistent with this model, the extracellular matrix under the endothelial cells critically modulates the signals induced by flow. In particular, PAK (p21-activated kinase) mediates critical aspects of this matrix specificity. The current project aims to elucidate the molecular mechanism for transduction by the junctional mechanotransduction complex and to test the role of PAK in atherogenesis in vivo. To achieve these overall goals we will: 1) measure forces across PECAM-1 and elucidate the role of the PECAM-1 cytoplasmic domain in mechanotransduction. 2) identify the protein interactions that mediate adapter function by VE-cadherin. 3) examine vascular inflammation and atherogenesis in PAK-deficient mice. PUBLIC HEALTH RELEVANCE: Atherosclerosis is a chronic inflammatory disease of arteries. Approximately half of all deaths in the United States are caused by heart attacks, strokes or other vascular events associated with atherosclerosis. While risk factors such as hyperlipidemia and diabetes are important risk factors, atherosclerosis is initiated and maintained at regions of arteries that are subject to disturbances in fluid flow. This project will investigate the molecular mechanisms of mechanotransduction in arteries that leads to atherosclerosis. Understand how fluid shear stress induces vascular inflammation is likely to identify new drug targets that may lead to more effective therapies to prevent or treat these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endothelial Mechanotransduction in Thoracic Aneurysm Formation and Progression
-
批准号:10378126
-
项目类别:
-
资助金额:$44.29万
-
财政年份:2018
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchyma transition and atherosclerosis
-
批准号:9219801
-
项目类别:
-
资助金额:$82.77万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchymal transition and atherosclerosis
-
批准号:10551998
-
项目类别:
-
资助金额:$83.56万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchymal transition and atherosclerosis
-
批准号:10330539
-
项目类别:
-
资助金额:$83.56万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
Endothelial-to-mesenchymal transition and atherosclerosis
-
批准号:9973898
-
项目类别:
-
资助金额:$83.56万
-
财政年份:2017
-
负责人:Martin A Schwartz
-
依托单位:
2012 Signaling by Adhesion Receptor Gordon Research Conference and Frontiers in A
-
批准号:8318467
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2012
-
负责人:Martin A Schwartz
-
依托单位:
ECM and shear stress
-
批准号:10433820
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2012
-
负责人:Martin A Schwartz
-
依托单位:
ECM and shear stress
-
批准号:10192388
-
项目类别:
-
资助金额:$52.05万
-
财政年份:2012
-
负责人:Martin A Schwartz
-
依托单位:
2011 Vascular Cell Biology Gordon Research Conference
-
批准号:8062789
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2011
-
负责人:Martin A Schwartz
-
依托单位:
Project 2: Integrin Signaling and Physical Forces
-
批准号:8234227
-
项目类别:
-
资助金额:$27.46万
-
财政年份:2011
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8505399
-
项目类别:
-
资助金额:$33.12万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
2010 Signalling by Adhesion Receptors Gordon Research Conference
-
批准号:7900217
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8319571
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8697021
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Understanding the RhoGDI2 metastasis suppressor gene
-
批准号:8147839
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2010
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7672486
-
项目类别:
-
资助金额:$72.74万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7463907
-
项目类别:
-
资助金额:$69.82万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7904865
-
项目类别:
-
资助金额:$71.24万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Engineering an Atherosclerosis-Resistant Endothelium
-
批准号:7290489
-
项目类别:
-
资助金额:$70.24万
-
财政年份:2007
-
负责人:Martin A Schwartz
-
依托单位:
Biosensor
-
批准号:7195625
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2006
-
负责人:Martin A Schwartz
-
依托单位:
海外基金